肿瘤医院ICU患者多药耐药菌定植的监测研究

发布时间：2018-01-21 09:09

  本文关键词： 多药耐药菌 定植 肿瘤　出处：《中华医院感染学杂志》2016年24期 　论文类型：期刊论文

【摘要】：目的了解肿瘤医院ICU多药耐药菌(MDROs)定植特点,分析其危险因素,为临床治疗提供参考依据。方法对医院2014年12月-2015年12月入住ICU 168名患者经鼻前庭拭子和肛拭子采集标本,进行多药耐药菌的筛查。结果 470份标本中共分离出多药耐药菌116株:其中产ESBLs大肠埃希菌114株,占98.2%,产ESBLs肺炎克雷伯杆菌2株,占1.7%。多因素logistic回归分析显示,入ICU时APACHEⅡ评分及入ICU前抗菌药物的使用是患者入ICU前合并MDROs定植的独立危险因素(P0.05)。结论重视MDROs的定植的高危因素,加强MDROs的预防控制,有效地预防医院感染。
[Abstract]:Objective to investigate the colonization characteristics of ICU multidrug resistant bacteria (MDROs) in tumor hospitals and analyze its risk factors. Methods from December 2014 to December 2015, the specimens of ICU patients were collected by nasal vestibular swab and anal swab. Results A total of 116 strains of multidrug resistant bacteria were isolated from 470 specimens, among which 114 strains (98.2% strains) produced ESBLs Escherichia coli. There were 2 strains of Klebsiella pneumoniae producing ESBLs, accounting for 1.7%. Multivariate logistic regression analysis showed. The APACHE 鈪，

本文编号：1451065